Complete cessation of urticaria Global assessment of symptom scores · patients with chronic spontaneous urticaria
Cetirizine 10 to 20 mg may leads to higher complete suppression of urticaria Global assessment of symptom scores compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · patients with chronic spontaneous urticaria
Cetirizine 10 to 20 mg showed no clear difference in adverse events leading to withdrawal compared with placebo (low certainty).
1 finding from 1 review
Complete suppression of urticaria: short‐term duration of intervention (levocetirizine 20 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria
1 finding from 1 review
Complete suppression of urticaria: intermediate‐term duration of intervention (levocetirizine 5 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria
1 finding from 1 review
Complete suppression of urticaria: short‐term duration of intervention (levocetirizine 5 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria
1 finding from 1 review
Complete suppression of urticaria: short‐term duration of intervention (levocetirizine 10 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria
1 finding from 1 review
Withdrawals due to adverse events · patients with chronic spontaneous urticaria
Cetirizine 10 mg showed no clear difference in adverse events leading to withdrawal compared with hydroxyzine 25 mg (low certainty).
1 finding from 1 review
Secondary outcome: clinical flare · adults with eczema
1 finding from 1 review
Pruritus · adults with eczema
1 finding from 1 review
Primary outcome 2. Proportion of participants reporting adverse effects and serious adverse events throughout the study period · adults with eczema
Cetirizine 10 mg/d showed no clear difference in primary outcome 2. Proportion of participants reporting adverse… compared with placebo (4‐week intervention) (low certainty).
1 finding from 1 review
Physician‐assessed changes in clinical signs · adults with eczema
1 finding from 1 review
Secondary outcome: quality of life · adults with eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
The proportion of participants with good or excellent rash improvement within 2 weeks, as rated by the participant · pityriasis rosea
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events, i.e. serious enough to require withdrawal of the treatment · pityriasis rosea
1 finding from 1 review
The proportion of participants with resolution of itch within 2 weeks, as rated by the participant · pityriasis rosea
Acyclovir + calamine + cetirizine may leads to higher the proportion of participants with resolution of itch within 2… compared with calamine + cetirizine (low certainty).
1 finding from 1 review
Reduction in itch score within 2 weeks, as rated by the participant · pityriasis rosea
1 finding from 1 review
The proportion of participants with good or excellent rash improvement within 2 weeks, as rated by a medical practitioner · pityriasis rosea
The review found no eligible studies for this question.
1 finding from 1 review
Minor participant‐reported adverse events not requiring withdrawal of the treatment: Headache. · pityriasis rosea
Acyclovir + calamine + cetirizine showed no clear difference in minor participant‐reported adverse events not requiring withdrawal… compared with calamine + cetirizine (low certainty).
1 finding from 1 review
Pruritus · children with eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Primary outcome 2. Proportion of participants reporting adverse effects and serious adverse events throughout the study period · children with eczema
Cetirizine 0.5 mg/kg/d showed no clear difference in primary outcome 2. Proportion of participants reporting adverse… compared with placebo (18‐month intervention) (moderate certainty).
1 finding from 1 review